Summary
Melanomas until recently had limited therapeutic options. Immunotherapy, has gained prominence as a therapeutic modality. Despite the high response rate to immunotherapy, it is necessary to decipher biomarkers that predict response to immunotherapy and assess resistance...
More information & hyperlinks
Web resources: | http://www.weizmann.ac.il/mcb/Samuels/ |